Neumora Therapeutics, Inc. Common Stock
USD1.72
+0.08 (+4.88%)
CEO
Daljit Singh Aurora
IPO Date
2023-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.60
Prev. Close
$1.64
Day Low
$1.60
Day High
$1.73
52W Low
$0.72
52W High
$3.65
Market Cap
$0.32B
Volume
1.64M
| -6.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -50.3% | -47.5% | 0.01 | 19.05 | -11.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 29.3% | -30.7% | -0.02 | 16.37 | -18.9 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 73.0% | -55.3% | -0.01 | 17.85 | -10.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 105.2% | -50.2% | -0.02 | 20.69 | -24.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | 0.0 |
| -1.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -42.9% | -31.9% | 0.00 | 6.85 | -1.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -28.8% | -23.6% | 0.11 | 10.54 | -0.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -29.8% | -26.5% | 0.00 | 8.98 | -0.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -20.5% | -18.6% | 0.01 | 10.51 | -7.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -22.6% | -20.6% | 0.01 | 10.98 | -7.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -15.4% | -14.5% | 0.01 | 17.22 | -6.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -12.7% | -11.9% | 0.01 | 17.99 | -10.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -23.2% | -21.9% | 0.01 | 19.05 | -6.2 |